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Objective: The role of anxiety in the use of urgent care in peoplewith long term conditions is not fully understood.
A systematic reviewwas conducted with meta-analysis to examine the relationship between anxiety and future
use of urgent healthcare among individuals with one of four long term conditions: diabetes; coronary heart dis-
ease, chronic obstructive pulmonary disease and asthma.
Methods: Electronic searches of MEDLINE, EMBASE, PSYCINFO, CINAHL, the British Nursing Library and the
Cochrane Library were conducted These searcheswere supplemented by hand-searching bibliographies, citation
tracing eligible studies and asking experts within the ﬁeld about relevant studies. Studies were eligible for inclu-
sion if they: a) used a standardised measure of anxiety, b) used prospective cohort design, c) included adult pa-
tients diagnosed with coronary heart disease (CHD), asthma, diabetes or chronic obstructive pulmonary disease
(COPD), d) assessed urgent healthcare use prospectively. Data regarding participants, methodology, and associ-
ation between anxiety and urgent care usewas extracted from studies eligible for inclusion. Odds ratioswere cal-
culated for each study and pooled using random effects models.
Results: 8 independent studies were identiﬁed for inclusion in the meta-analysis, with a total of 28,823 indi-
vidual patients. Pooled effects indicate that anxiety is not associated with an increase in the use of urgent care
(OR = 1.078, p = 0.476), regardless of the type of service, or type of medical condition.
Conclusions:Anxiety is not associatedwith increased use of urgent care. Thisﬁnding is in contrast to similar stud-
ies which have investigated the role of depression as a risk factor for use of urgent care.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Long term conditions (LTCs) are common and are associated with
high healthcare costs. Globally, 50–80% of all healthcare spending is re-
lated to LTCs [1]with approximately 78% of the entire healthcare budget
of theUnited States of America spent on providing healthcare for people
with LTCs [2] and 69% of the healthcare budget in England allocated to
the care of individuals with LTCs [3]. A disproportionate amount of
healthcare costs are spent on urgent healthcare, some of which may
be avoidable [4–6]. In the UK, there has been an increase in the use of
urgent care over the last decade with an ever increasing number of
patients presenting to Emergency Departments [7–9]. The reason for
this is likely to be multi-factorial and to include factors related to
organisational issues around the delivery of healthcare, disease severity,
an ageing population with complex disease co-morbidity, and a variety
of other, as of yet, unidentiﬁed factors.
Depression and anxiety and common co morbidities of LTCs and are
associated with negative health outcomes such as: signiﬁcant role im-
pairment [10,11], increased physical morbidity [12,13] increased mor-
tality [14,15], poorer quality of life [16,17], increased re-admission
rates following hospital discharge [18–20], increased healthcare costs
[21–23], and loss of work days [24–26]. However, much research has
focused on the relationship between depression and LTCs, and less is
known about the effect of co-morbid anxiety disorders. Anxiety disor-
ders occur in approximately 18.1%–33% of the general population at
any period of time [27,28] and the lifetime prevalence is approximately
28.8% [27]. The prevalence of anxiety symptoms in LTCs is much higher
than that in the general population, reaching up to 69% for some condi-
tions [29,30]. Anxiety disorders are associated with signiﬁcant
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functional impairment and poor disease control in the context of certain
LTCs [31,32].
In a recent systematic review, it was shown that depression is asso-
ciated with an increase in the use of urgent care in people with LTCs by
approximately 50% [23]. However, the impact of anxiety on urgent care
use remains unclear. Therefore, we have conducted a systematic review
of the literature with meta-analysis to clarify the extent to which anxi-
ety predicts urgent care use in people with LTCs.
Method
Four non-communicable, exemplar LTCs were chosen for the pur-
poses of the review: chronic obstructive pulmonary disease (COPD),
coronary heart disease (CHD), asthma and diabetes. These four condi-
tions contribute as the leading non-communicable causes of death
worldwide, when excluding cancer [33].
Themethods and results for this review are reported in linewith the
PRISMA Guidlelines [34].
Eligibility criteria
The study team included papers which met the following criteria;
1. Included adults (over 18 years of age) with one or more of the
following LTCs: diabetes (type 1, type 2 or unspeciﬁed), asthma
(acute or chronic), COPD (acute or chronic), or CHD (myocardial in-
farction, stable or unstable angina), presenting results independently
to any further LTMCs not included in the review criteria.
2. Prospective cohort study design.
3. Included a standardised measure of anxiety at baseline.
4. Assessed urgent healthcare use prospectively.
Urgent care was deﬁned as any of the following: unscheduled visits
to GP, consultant, or specialist nurse; visits to accident and emergency,
walk in clinics, or other urgent hospitalizations; as well as costing data
for these events.
In order to maximise the number of studies included within the
review we did not exclude studies due to the way in which anxiety
was assessed provided that patients were assessed using a valid,
standardised anxiety measure. We also included all studies which
used prospective, standardised measures of urgent care.
Studies were included within the review regardless of date or lan-
guage of publication, sample size or length of follow up period. Papers
presented in non-English languages were translated prior to screening.
However, studies only available in conference abstract form, or as of the
time of searching, unpublished papers, were not included in the review.
This decision was made so as to ensure papers included were of high
methodological quality, and typical of other published papers included.
See Appendix A for full exclusion and inclusion criteria.
Study selection
Team members with experience of conducting systematic reviews
conducted in-team electronic search strategies in MEDLINE, EMBASE,
PSYCHINFO, CINAHL, The British Nursing Index (using OVID search in-
terface) and the Cochrane Library, retrieving papers from the inception
of each of these databases up until the search date. Search strategies
included terms of reference relevant to CHD, COPD, asthma and/or dia-
betes, as well as terms relevant to healthcare use, and were limited to
prospective studies (see Appendix A for detailed accounts of search
strategies used). As there was no medical subject heading (MeSH)
terms relevant to the use of unscheduled care, electronic searches
were conducted for studies relevant to all healthcare utilisation. The
subset of studies that collected data on unscheduled care was identiﬁed
by the research teamhand-searching studies of all healthcare utilisation.
Electronic searches were ﬁrst conducted in 2008 and updated peri-
odically until 2013. Electronic searches were supplemented by hand
searches of papers meeting inclusion criteria, and relevant papers
were citation searched using the Social Science Citation Index.
Titles and abstracts of papers were screened by one of ﬁve re-
searchers (AB, AK, CB, CH, and JJ) in order to identify any studies
which potentially met the study inclusion criteria. Full texts of any po-
tentially relevant papers were then screened in full by two researchers
independently to assess suitability. These were then discussed in pairs,
and any disagreements were resolved through discussion and/or
screening by a third researcher.
Authors were contacted for further information where results did
not specify the effect of anxiety as an independent factor on the use of
urgent healthcare, where healthcare was not speciﬁed as urgent or
non-urgent, andwhere data on urgent healthcare usewere not present-
ed separately. Fifteen authorswere contacted and nine respondedwith-
in the pre-determined time frame of two weeks. Of the nine authors
who responded, six were able to provide us with the requested data
(see Appendix A for full information on studies included and excluded
after author contact). Fig. 1 displays a summary of the study selection
process.
Data extraction
Standardised data extraction sheets developed by study teammem-
bers and piloted on previous occasions were used to extract data from
studies included in the review. Data was extracted from the studies re-
garding participant characteristics, measure of anxiety used, measure of
urgent care use, and the strength of association between anxiety and ur-
gent care (both univariable andmultivariable associationswere extract-
ed where possible).
Primary data extraction was performed on each included paper in-
dividually by two of ﬁve researchers (AB, AK, CB, CH, JJ), and compared
between twomembers to ensure consistency in extracted data. Any dis-
agreements were resolved through discussion.
Risk of bias in individual studies
The Quality Assessment Tool for Quantitative Studies was used in
order to assess the methodological quality of individual studies [35,
36], dependent on whether there was:
a) An absence of selection bias for participants
b) Appropriate study design
c) Adequate control for confounding factors
d) Participants blinding to research question
e) Assessors blinding to participant's anxiety status
f) Valid and reliable data collection methods
g) Appropriate action taken for participant withdrawal
h) Appropriate use of analytical methods (The item of quality assess-
ment relating to the integrity of interventions was excluded from
the assessment).
Two researchers independently assessed the quality of studies; with
consensus being reached through discussion when any disagreements
occurred (the full quality assessment can be found in Table 3).
Statistical analysis
Odds ratios (OR) and 95% conﬁdence intervals (95% CIs) were ex-
tracted or calculated for each study where the number of participants
using urgent care with and without anxiety was presented alongside
the total number of subjects within each group. ORs N 1 indicated that
anxiety was associated with an increased use of unscheduled care.
Where study data was presented in alternative formats (e.g. contin-
uous data, p-value comparisonswith group sizes, or as correlations), ap-
propriate transformations were conducted using Comprehensive Meta
Analysis software.
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For data collected at multiple follow-up time points, ORs were calcu-
lated for the timepoint closest to 1 year in order tomaximise consistency
across studies.Where studies includedmore than onemeasure of urgent
healthcare, ORs for each measure were averaged, ensuring that each
study contributed only one effect measure to the meta-analysis [37].
ORs for anxiety were combined across the studies included using
the DerSimonian and Laird random effects method [38], with heteroge-
neity among studies assessed using the Cochrane Q and I2 statistic [39,
40]. The I2 statistic is a measure of the percentage of variability in the
effect estimate that is due to heterogeneity rather than due to chance.
The suggested thresholds for the interpretation of I2 are b25% suggesting
low heterogeneity, b50% which suggests moderate heterogeneity, and
N75% which suggests high heterogeneity [39].
Effects for anxiety are presented in both text and forest plot format.
Meta-analyses were performed using ComprehensiveMeta-analysis
(version 2.2.048, November 7th 2008). See Appendix A for the meta-
analysis formulae used.
Results
Eight independent studies were identiﬁedwhich met the criteria for inclusion [19,20,
41–46], providing data from a total of 28,823 participants (range n = 37 to 26,591). The
eight studies were conducted in various countries; two in the United Kingdom; one in
the United States of America, China, Netherlands, Germany and Canada; and one study in-
cluding ﬁve Nordic countries (Finland, Norway, Iceland, Sweden andDenmark). The stud-
ies detailed patients diagnosedwith COPD [19,20,45,46], asthma [41,42,44], and CHD [43].
See Table 1 for full characteristics of the studies included.
Anxiety was assessed using self-report questionnaires in seven out of eight studies
[19,20,41–45], with one study using the ICD-9 diagnostic codes taken from patients'
notes [46]. There were no cases when more than one measure of anxiety was presented.
Four studies assessed the use of urgent care using self-report questionnaires [19,41,43,
45], and six studies used hospital admission and medical records [19,20,42–44,46].
Of the eight studies included in the review, none showed signiﬁcant effects of anxiety
on the use of urgent healthcare, with only one paper showing near signiﬁcant effects [41].
The independent study effects are presented in the forest plot (Fig. 2). The combined
effect (OR) for anxiety across all studies included in the analysis was OR = 1.078 (95%
CI 0.877–1.325), p = 0.476. Effects of individual studies showed a relatively low level of
heterogeneity (Q=9.5, d.f.= 7, p= 0.221, I2= 26.07%),which is supported by the insig-
niﬁcance of Q. [46] included amuch larger sample size than the remaining seven papers in
the review, with a total of 26,591 patients, of whom 97% were male. Further sensitivity
analysis was conducted in order to assess whether this study affected the meta-analysis
outcome. The combined effect (OR) for anxiety across these studies was OR = 1.238
(95% CI 0.969–1.551), p = 0.087 (see Appendix A). Effects of these studies showed a
very low level of heterogeneity (Q = 5.116, d.f. = 5, p = 0.402, I2 = 2.27%), which is
again supported by the insigniﬁcance of Q.
Effects of anxiety did vary across the different types of urgent care used between stud-
ies although none of the effectswere signiﬁcant: ED visits [n=1, OR= 1.360 (95% CI 0.889,
2.081), p= 0.156], hospitalisation [n=5, OR= 1.002 (95% CI 0.876, 1.146), p= 0.976], GP
visits, ED or hospitalisation [n = 1, OR = 0.616 (95% CI 0.250, 1.516), p = 0.291],
and combined hospitalisation and GP visits [n = 1, OR = 4.099 (95% CI 0.935, 17.965),
p= 0.061]. Comparison across groups using the analog of ANOVA revealed that these dif-
ferences in effect size across various types of urgent care were not statistically signiﬁcant
(Q = 6.4, d.f. = 3, p = 0.093).
The effect of anxiety also varied across the different LTMCs included in the review;
however none of the effects were signiﬁcant: asthma [n = 3, OR = 1.355 (95% CI 0.462,
3.976), p = 0.580]; CHD [n = 1, OR = 1.360 (95% CI 0.889, 2.081), p = 0.156]; COPD
[n= 4, OR= 0.998 (95% CI 0.872, 1.143) p= 0.978]. Comparison across groups revealed
that these differences in effect size across the different LTCs were not statistically signiﬁ-
cant (Q = 2.1, d.f. = 2, p = 0.350).
The pooled meta-analysis was repeated for the studies grouped according to their
methodological quality rating. This revealed the following effect sizes: methodologi-
cally strong studies: n = 2, OR = 0.927 (95% CI 0.701, 1.226), p = 0.594; methodolog-
ically moderate studies: n = 4, OR = 1.243 (95% CI 0.650, 2.375), p = 0.511;
methodologicallyweak studies: n=2, OR= 1.258 (95% CI 0.955, 1.656), p= 0.102. Com-
paring effects across studies grouped by methodological quality using the analog of
ANOVA revealed no signiﬁcant difference in the effect sizes (Q= 2.5, d.f. = 2, p= 0.288).
Multivariable analysis
Of the 8 studies included, only 4 reported conducting multivariable analysis that con-
trolled for severity of the LTC among other covariates {Grace et al. [43]; Abrams et al. [46];
Gudmundsson et al. [19]; Coventry et al. [20]}. These 4 studies used various measures of
Idenficaon
Screening
Eligibility
Included
Records idenfied 
through database 
searching (n=19,556)
Records aer duplicates removed (n=18,246)
Aer records tles or abstracts screened (n=378)
Full texts excluded, with reasons (n=370)
Reasons:
No Measure of anxiety (n= 155)
Not prospecve cohort study (n= 77)
No psychosocial predictors (n= 41)
Not relevant long term medical conditions (n= 39)
Reviews (n =8)
Included children (n = 3)
Studies included in 
quantave synthesis 
(meta-analysis) (n= 8)
Addional records idenfied 
through other sources (searching 
reference lists and citaon 
searching included papers (n= 1914)
Arcle suggested 
aer discussing with 
experts in field (n=1)
Fig. 1. PRISMA ﬂow diagram.
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severity of LTC including cardiac event occurrence, length of exacerbation, St. George's Re-
spiratory Questionnaire (SGRQ) and 30 day readmission.
Based on the reported results of multivariable analysis, where illness severity was
controlled for, anxiety did contribute signiﬁcantly to the multivariable models in two of
the four studies. Grace et al. [43] found that depression; older age and a history of cardio-
vascular disease were signiﬁcant predictors of self-reported recurrent cardiac events,
whereas anxiety led to signiﬁcantly less self-reported cardiac events (OR = 0.35,
95% CI = 0.19–0.65, p = b0.01). Gudmundsson et al. [19] found anxiety was
Table 1
One study characteristics.
1st author
and date
Condition
of study
Sample
size
Mean age
(years)
%
Males
Sample characteristics Anxiety measure Urgent healthcare
utilisation/cost
measure
[46] COPD 26,591 69.1
(SD 11.1)
97% Veterans with principal diagnosis of COPD exacerbation, acute or
chronic bronchitis, chronic obstruction of the airway not elsewhere
classiﬁed or acute and chronic respiratory failure. Excluded repeat
admissions, cases with no ICD code of acute exacerbation of COPD
(primary or secondary); no outpatient encounters in a year prior
to admission; veterans admitted to facility with no acute care status
or not initially admitted to an acute medical ward.
ICD-9 Veteran Association
30 day re-admission
records
[41] Asthma 256 56.3
(SD 16.4)
38.3% Previously performed spirometry or broncho-provocation. Attacks
of dyspnoea and wheezing or with a known allergy. Heavy smokers
likely to have COPD were to be avoided.
Validated German PHQ Patient self-reported
use
[42] Asthma 74 40.6 27% Asthma attacks during the 20 months from October 1997. Control
was selected from practice lists of patients identiﬁed as ever having
asthma, only patients considered to have active asthma with duration
of at least 3 years were included. The other group were patients with
stable asthma matched to the other group in age, sex and BTS
treatment. For more severe asthmatics, controls had to have not had
an attack for a year.
7 item panic fear scale
of asthma symptom checklist,
practice records & ACCS
Practice records A&E
attendance and hospital
attendance
[43] CHD 913 61.89
(SD 12)
64.8% Consecutive patients who were diagnosed with MI or UA in 12 CCUs
across South-central Ontario, Canada. Diagnosed with a conﬁrmed MI
or unstable angina (UA) and were 18 years of age or older. Patients
who were medically unstable or unable to read or speak English were
excluded.
MHQ and Anxiety Subscale
of the PRIME-MD
Patient self-reports
on use
[44] Asthma 40 37.2
(SD 14)
37.5% Diagnosis of asthma, Netherlands natives between the ages of 16
and 60 years.
ASC-PF, STAI-DY, 20 PF,
and NPV
Not stated
[45] COPD 491 Not stated b66% 30 years N; physician-diagnosed COPD; post bronchodilator FEV1/FVC
ratio of less than 0.7 and FEV1 of less than 80% of predicted value; no
fever, no worsening of respiratory symptoms, and no medication
change within 4 weeks before recruitment; no primary diagnosis of
asthma; no previous lung volume reduction surgery, lung
transplantation, or pneumonectomy; and expected survival
N 6 months.
Mandarin HADS Patient self reports
on use
[19] COPD 416 69.2
(SD 10.5)
48.8% Admitted for N24 h with acute exacerbations of obstructive lung
disease (asthma, chronic bronchitis, chronic obstructive bronchitis or
emphysema) during the year 2000–2001. Fulﬁlled criteria for COPD
according to the Global initiative for chronic obstructive pulmonary
disease (GOLD) stage I or higher. No diagnosis of asthma.
HADS Patient self-report
on use
[20] COPD 79 65.3
(SD 9.9)
44% Validated diagnosis of COPD, with post-bronchodilator FEV1 b 80% of
predicted, FEV/FVC ratio b70%. MMSE N7, Systolic BP N 100 mm Hg,
white cell count (×109/1) 4–20, potassium between 3.5 and 5 mmol/l,
arterial blood pH N 7.35, pO2 N 8 kPa, pCO2 b 6.7 kPa, registered with
Manchester GP with adequate social support. Exclusions; suspected
underlying malignancy, pneumothorax, uncontrolled atrial ﬁbrillation,
acute ECG changes, full time nursing, IV therapy, cardiac chest pain,
insulin dependent diabetes, pneumonia/consolidation, chest X-ray
changes, pulmonary embolism, history of falls, severe and enduring
mental health problems, not English speaker.
HADS Medical records
Study name Physical condition psychosocial measure Outcome Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit Z-Value p-Value
Abrams COPD ICD-9 hosp 0.974 0.837 1.133 -0.343 0.732
Coventry COPD HADS A score hosp 0.614 0.272 1.387 -1.173 0.241
Grace CHD PRIME-MD anxiety DSM-IV ED visits 1.360 0.889 2.081 1.418 0.156
Greaves Asthma ASCL panic scale GP, ED or hosp 0.616 0.250 1.516 -1.055 0.291
Gudmundsson COPD HADS A score
ASC-PF, STAI-DY, 20 PF, and NPV
hosp 1.189 0.829 1.705 0.941 0.347
Kaptein Asthma Combined 1.434 0.397 5.179 0.550 0.582
Schneider Asthma German PHQ DSM-IV panic Combined 4.099 0.935 17.965 1.871 0.061
Xu COPD Chinese HADS anx >=8 hosp 1.243 0.621 2.487 0.614 0.539
1.078 0.877 1.325 0.713 0.476
0.01 0.1 1 10 100
Favours A Favours B
Anxiety and unscheduled care
Fig. 2. Forest plot anxiety and unscheduled care.
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signiﬁcantly associated with increased risk of urgent hospitalisation in a subgroup of pa-
tients who had poor health related quality of life, when analysed using Cox regression,
Hazard ratio (HR) = 1.73 (95% CI, 1.18–2.53). Coventry et al. [20] found that the only sig-
niﬁcant predictors of readmission within 365 days of discharge were depression, odds
ratio (OR) = 1.300 (95% CI, 1.06–1.60), p = 0.013, FEV, OR = 0.962 (95% CI, 0.93–
0.99), p = 0.021, and age, OR = 1.092 (95% CI, 1.01–1.18), p = 0.026. Abrams et al.
[46] found that controlling for smoking status made no changes to the effect of anxiety
on risk of admission (smoking present HR = 1.22 (95% CI 1.04–1.44), smoking absent
HR = 1.22 (95% CI 1.03–1.43)). See Table 2 for a full description of results.
Risk of bias within individual studies
Details of the quality of studies included within the analysis are presented in Table 3.
Two studies were rated as strong (no weak ratings) [20,46], four were rated as moderate
(oneweak rating) [41,42,44,45] and twowere rated as weak (more than oneweak rating)
[19,43].
Publication bias
The contour enhanced funnel plot did not appear to be asymmetrical, except for one
small negative study (Fig. 3), and Egger's regression method conﬁrmed the lack of associ-
ation between logeOR and standard error of logeOR. Egger's bias = 1.24, 95% CI−1.01 to
3.48, p = 0.23.
The Duval and Tweedie trim and ﬁll procedure created just 1 imputed study, giving a
revised random effects combined odds ratio for anxiety across all studies of 1.05 (95% CI
0.82 to 1.33), p = 0.69 (see Appendix A). This is only very slightly reduced compared
with the original, and still not signiﬁcant. The heterogeneity between studies is increased
slightly, and still signiﬁcant (Q = 12.9, df = 8, p = .040).
Discussion
A systematic review with meta-analysis was conducted to determine
whether anxiety is associated with the use of urgent care in patients with
LTCs.On combiningunivariateﬁndings from8 independent studies, anxiety
was not signiﬁcantly associatedwith increased use of urgent healthcare. Ef-
fects for anxiety were also not statistically signiﬁcant across different types
of urgent healthcare use or different LTCs. Ourﬁndingswerenot signiﬁcant-
ly inﬂuenced by studies with lowmethodological quality. Three out of the
four studies presenting multivariable analyses suggested anxiety had
some effect on either urgent healthcare use, exacerbation in days, or recur-
rent illness, independentof severityof anxiety.However, these three studies
which reported positive associations had relatively poorer methodological
quality than the study which reported no such ﬁndings [20].
Our review has several strengths. First we conducted extensive
searching of key electronic databases and sought expert advice frompro-
fessionalswithin the area on potentially relevant studies. This enabled us
to identify asmany relevant studies as possible. Furthermore, to increase
the identiﬁcation of relevant papers, we chose not to limit search terms
to urgent healthcare, instead we kept search terms broad, searching all
healthcare use ﬁrst and then hand-searching the results to ﬁnd papers
relevant to urgent care. Our methodological quality was further en-
hanced by inclusion of all relevant papers, regardless of year of publica-
tion, language of publication, sample size, or duration of follow-up. Data
extraction was conducted by independent researchers with ﬁndings
Table 2
Main ﬁndings of studies included in review.
Author
& date
Univariable ﬁndings Factors controlled Multivariable ﬁndings
[46] Patients with anxiety were not more signiﬁcantly
likely to be readmitted than those without anxiety
(11.3% vs. 11.5% [NS]).
Smoking status. No signiﬁcant difference in risk of admission
regardless of smoking status. Smoking present
HR = 1.22, 95% CI 1.04–1.44, smoking absent
HR = 1.22, 95% CI 1.03–1.43.
[41] Panic disorder did not predict hospitalisation
(OR = 3.5, 95% CI = 0.7–18.3, p = 0.145), but
did predict emergency visits (OR = 4.8, 95%
CI 1.3–17.7, p = 0.019).
[42] There was no main effect of panic (p N 0.05).
[43] Anxious patients (1.11 [1.57]) reported more visits
to the emergency department than non anxious
(0.83 [1.18]) patients (t = −1.37, p = 0.17).
However, this was NS.
Age, family history of CVD, depression, Killip
class, sex, family income, smoking status,
diabetes and phobic anxiety.
Age (OR = 1.02, 95% CI 1.00–1.05, p = 0.05),
family history of CVD (OR = 1.63, 95% CI 1.04–2.54,
p = 0.03), depression (OR = 1.07, 95% CI 1.03–1.12,
p = b0.01) and prime-MD anxiety at 6 months
(OR = 0.35, 95% CI = 0.19–0.65, p = b0.01), were
all signiﬁcant predictors of self-reported recurrent
cardiac events. All other factors NS.
[44] State and trait anxiety not associated with
increased length of hospitalisations.
State anxiety not signiﬁcantly associated with
readmission, however trait anxiety had slight
effect (1-tailed t = 1.72, p = 0.048).
[45] Anxiety not associated with increased risk of
urgent hospital admission (p = 0.11), however
length of exacerbation in days was longer for
patients with anxiety than for those without
(p = 0.03).
Age, sex, smoking, marital status, education,
employment, living situation, FEV1, dyspnoea
score, six-minute-walk distance, social support,
chronic obstructive pulmonary disease-speciﬁc
self-efﬁcacy, signiﬁcant comorbidities, hospital
type, use of long-acting bronchodilator and
inhaled corticosteroid, long-term oxygen
therapy and past hospitalisation.
Anxiety was not associated with hospitalisation:
Incidence Rate Ratio = 1.63 (0.88 to 3.03) for HADS
anxiety ≥ 11, or for lengthy of hospitalisation for
those readmitted: IRR = 1.99 (0.59 to 6.72).
[19] Anxiety had no signiﬁcant effect on
rehospitalisation (p = 0.61). No signiﬁcant
difference between HADS anxiety scores for
those who were readmitted (7.1 [4.3]) and
those who were not (6.7 [4.0], p = 0.28)
Age smoking status, FEV, SGRQ. Signiﬁcant association between the HAD anxiety
score and the risk of re-admission in patients with a
low health status (HR = 0.81 95% CI = 0.63–1.04).
In the same group, anxiety (HADS score ≥ 8) was
related to increased risk of rehospitalisation
(HR = 0.43 95% CI = 0.25–0.74).
[20] No signiﬁcant difference between HADS
anxiety scores for those who were readmitted
(8.53 ± 4.2) and those who were not
(9.47 ± 4.6, p = 0.407)
Age, race, gender, individual medical
comorbidities and laboratory values.
Depression (OR = 1.300, (95% CI, 1.06–1.60),
p = 0.013), FEV score (OR = 0.962, (95% CI, 0.93–0.99),
p = 0.021), and age (OR = 1.092, (95% CI, 1.01–1.18),
p = 0.026) were the only signiﬁcant predictors of
readmission. Anxiety was insigniﬁcant.
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compared between researchers, to ensure reliability of results. We be-
lieve that our methodological rigour in identifying relevant papers con-
tributed to the homogeneity of our ﬁndings within the analysis.
Our review has several limitations. Firstly, our decision to limit the
review to four exemplar LTCs means that our ﬁndings may not be
generalisable to all LTC populations. However, COPD, CHD, asthma and
diabetes are all common conditions [33] with relatively high levels of
psychological morbidity [47]. Three of the four LTCs are considered to
be among the most burdensome non-communicable diseases world-
wide [33] and are among the leading patient discharge diagnoses from
emergency departments [48].
A second limitation is that we rated studies using a quality scoring
system, which categorised studies according to the number of ‘weak’
characteristics displayed within the paper. The main advantage of
doing this is that it allowed us to conduct sensitivity analyses to investi-
gate the impact of quality on the observed effects of anxiety on urgent
healthcare use. We recognise that in presenting quality extraction
data in this way, it could be argued that we assumed all methodological
weaknesses to carry an equal weight, so we have also included with-
in the paper a table displaying how each study was scored, to enable
readers to interpret quality themselves. Finally, the number of relevant
papers included in this paper was quite small, with the result that our
meta-analysis lacked statistical power. However, we do not think that
a lack of power has affected the main result; OR for anxiety on urgent
healthcare= 1.08 is very small and of little if any clinical signiﬁcance ir-
respective of the statistical signiﬁcance. Some of the subgroup analyses,
for example, those demonstrating differences in effect across type of
urgent care or type of long term condition, were quite large inmagnitude
(differences in odds ratios up to 70%) but failed to reach statistical signif-
icance, which may, at least in part, be due to a lack of statistical power.
Our original hypothesis was informed by literature which did not
meet the criteria for inclusion in this review but suggested that anxiety
signiﬁcantly increased the healthcare use of some patientswith our four
speciﬁed LTCs [49–52], as well as in other LTCs such as irritable bowel
syndrome (IBS) [53] and sickle cell disease [54]. Whilst differences
between different LTCs may be expected, the ﬁndings suggestive of a
link between anxiety and urgent care in our 4 exemplar conditions,
primarily arise from studies that have employed a cross sectional de-
sign. Our ﬁndings from this systematic review, suggest that the relation-
ship between anxiety and use of urgent care becomes much weaker, if
patients are studied prospectively. This is supported by ﬁndings from
prospective cohort studies which have investigated other LTCs [55,56]
Table 3
Quality assessment.
Author
& date
Selection
bias
Design Confounding Blinding Data
collection
Drop
outs
Global
rating
Discrepancy
between
reviewers
Reasons for
discrepancy
Final
rating
[46] 1 2 1 2 1 1 1 N 1
[41] 3 2 2 2 1 2 2 N 2
[42] 2 2 3 2 1 1 2 Y Blinding
procedure
2
[43] 3 2 1 2 3 2 3 N 3
[44] 1 2 3 2 2 1 2 N 2
[45] 3 2 1 2 1 1 2 N 2
[19] 3 2 1 2 1 3 3 N 3
[20] 2 2 2 2 1 2 1 N 1
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Fig. 3. Contour enhanced funnel plot: logeOR vs standard error of logeOR.
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which suggest anxiety does not play a role in inﬂuencing urgent
healthcare use.
Anxiety is clearly associated with a variety of poor outcomes in
peoplewith LTCs [31,32,65,66]. A possible explanation for the ‘lack of ef-
fect’ of anxiety on urgent care may be that it is difﬁcult to disentangle
the impact of anxiety on healthcare use from the effects of co-morbid
depressive symptoms. In a previous systematic review and meta-
analysis depression was shown to be associated with an increased risk
of up to 50% in the use of urgent care in patients with LTCs [23]. Depres-
sion and anxiety are highly correlated [57,58] and often co-occur [59].
However, our ﬁndings suggest that theremay be characteristics speciﬁc
to depression that lead to a greater use of urgent care; characteristics
which are not found in anxiety. It is possible that depression results in
greater self neglect [60,61] and less adherence with routine treatment
[62,63], which then leads on to more acute illness exacerbations and
greater need for urgent care. Depression is also associatedwith negative
self efﬁcacy, which may make it particularly difﬁcult for people to cope
at times of ‘health crises’ [64].
Anxiety may only present a signiﬁcant effect on use of urgent care
within people with LTCs when associated with other psychological
factors such as health related quality of life [67,68]. Or it may be that
certain anxiety disorders, such as panic disorder, have a greater impact
on use of urgent care than generalised anxiety [69]. It was not possible
to address these questionswithin the scope of this reviewdue to the rel-
atively small number of studieswe identiﬁed. However, as the literature
develops in this area, future reviews could use techniques such asmeta-
regression to tease out the impact of a wider range of more speciﬁc psy-
chological variables on use of urgent care.
Although our ﬁndings suggest anxiety is not associated with use of
urgent care, it is associated with many other adverse outcomes. There
remains a requirement to identify and treat anxiety in peoplewith LTCs.
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